290 related articles for article (PubMed ID: 8658816)
1. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
Maeda H; Sakamoto K; Kashiwabara H; Hachisu T; Yamada H; Matsushita K; Yamada K; Yokoyama T
Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816
[No Abstract] [Full Text] [Related]
2. Effect of subclinical rejection on renal allograft histology and function at 6 months.
Rush D; Jeffery J; Trpkov K; Solez K; Gough J
Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
[No Abstract] [Full Text] [Related]
3. The detrimental effect of early rejection on long-term renal allograft outcome.
Sumrani N; Delaney V; Daskalakis P; Hong JH; Cacciarelli TV; Sommer BG
Transplant Proc; 1992 Oct; 24(5):1750-2. PubMed ID: 1412824
[No Abstract] [Full Text] [Related]
4. Accelerated acute rejection in renal allograft.
Han DJ; Yoon HS; Lee HM
Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
[No Abstract] [Full Text] [Related]
5. Hypertension in renal transplant recipients and its effect on long-term renal allograft survival.
Kokado Y; Takahara S; Kameoka H; Okuyama A
Transplant Proc; 1996 Jun; 28(3):1600-2. PubMed ID: 8658802
[No Abstract] [Full Text] [Related]
6. Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.
Vanrenterghem Y; Peeters J
Transplant Proc; 1996 Aug; 28(4):2097-9. PubMed ID: 8769165
[No Abstract] [Full Text] [Related]
7. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
[No Abstract] [Full Text] [Related]
8. Renal transplantation in cyclosporine-treated patients with end-stage lupus nephropathy.
Sumrani N; Miles AM; Delaney V; Daskalakis P; Markell M; Hong JH; Friedman EA; Sommer BG
Transplant Proc; 1992 Oct; 24(5):1785-7. PubMed ID: 1412843
[No Abstract] [Full Text] [Related]
9. Cyclosporine monotherapy in children: long-term effect.
Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
Transplant Proc; 1994 Oct; 26(5):2610-6. PubMed ID: 7940813
[No Abstract] [Full Text] [Related]
10. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of OKT3-treated renal transplant recipients.
Tanabe K; Takahashi K; Sonda K; Tokumoto T; Koga S; Nakazawa H; Goya N; Yagisawa T; Fuchinoue S; Kawai T; Toma H; Ota K
Transplant Proc; 1996 Jun; 28(3):1350-1. PubMed ID: 8658689
[No Abstract] [Full Text] [Related]
12. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
Sumrani N; Hong J; Miles A; Markell M; Distant D; Fleishhacker J; Maursky V; Jean-Baptiste F; Sommer B
Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
[No Abstract] [Full Text] [Related]
14. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
15. Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy.
Maachi K; Berthoux P; Burgard G; Alamartine E; Berthoux F
Transplant Proc; 1995 Feb; 27(1):846-9. PubMed ID: 7879202
[No Abstract] [Full Text] [Related]
16. Effect of nifedipine on renal allograft function and survival beyond one year.
Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin AL; Stenzel KH
Clin Nephrol; 1997 Jan; 47(1):33-6. PubMed ID: 9021239
[TBL] [Abstract][Full Text] [Related]
17. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
18. Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study.
Morales JM; Rodriguez-Paternina E; Araque A; Andres A; Hernandez E; Ruilope LM; Rodicio JL
Transplant Proc; 1994 Oct; 26(5):2598-9. PubMed ID: 7940807
[No Abstract] [Full Text] [Related]
19. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
Morales JM; Campistol JM; Kreis H; Mourad G; Eris J; Schena FP; Grinyo JM; Nanni G; Andres A; Castaing N; Brault Y; Burke JT
Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504
[TBL] [Abstract][Full Text] [Related]
20. A single-center multiple regression analysis of covariates associated with long-term cadaveric renal allograft survival: further improvement of long-term results with CsA.
Peeters J; Christiaens MR; Coosemans W; Donck J; Roels L; Verberckmoes R; Waer M; Vanrenterghem Y
Clin Transpl; 1995; ():255-60. PubMed ID: 8794271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
